CEPHRADINE: 45 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
45
Total FAERS Reports
4 (8.9%)
Deaths Reported
9
Hospitalizations
45
As Primary/Secondary Suspect
5
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
FDA Application: 050530 ·
First Report: 20070618 · Latest Report: 20241204
What Are the Most Common CEPHRADINE Side Effects?
#1 Most Reported
Drug hypersensitivity
9 reports (20.0%)
#2 Most Reported
Pruritus
8 reports (17.8%)
#3 Most Reported
Rash
6 reports (13.3%)
All CEPHRADINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 9 | 20.0% | 0 | 1 |
| Pruritus | 8 | 17.8% | 0 | 1 |
| Rash | 6 | 13.3% | 0 | 2 |
| Anaphylactic shock | 5 | 11.1% | 0 | 0 |
| Angioedema | 5 | 11.1% | 0 | 0 |
| Bronchospasm | 5 | 11.1% | 0 | 0 |
| Hypotension | 5 | 11.1% | 0 | 0 |
Who Reports CEPHRADINE Side Effects? Age & Gender Data
Gender: 69.2% female, 30.8% male. Average age: 50.9 years. Most reports from: US. View detailed demographics →
Is CEPHRADINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 3 | 2 | 0 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 1 |
| 2015 | 2 | 1 | 2 |
| 2018 | 4 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 0 |
| 2024 | 1 | 0 | 0 |
What Is CEPHRADINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 11 |
Official FDA Label for CEPHRADINE
Official prescribing information from the FDA-approved drug label.